Interleukin-9 Aggravates Isoproterenol-Induced Heart Failure by Activating Signal Transducer and Activator of Transcription 3 Signalling

Lyon, 2015, Mechanotransduction in cardiac hypertrophy and failure, Circ Res, 116, 1462, 10.1161/CIRCRESAHA.116.304937 Ezekowitz, 2017, 2017 Comprehensive update of the Canadian Cardiovascular Society guidelines for the management of heart failure, Can J Cardiol, 33, 1342, 10.1016/j.cjca.2017.08.022 Fukuda, 2018, Elucidation of the strongest predictors of cardiovascular events in patients with heart failure, Ebiomedicine, 33, 185, 10.1016/j.ebiom.2018.06.001 Drews, 2010, Differential regulation of proteasome function in isoproterenol-induced cardiac hypertrophy, Circ Res, 107, 1094, 10.1161/CIRCRESAHA.110.222364 Lohse, 2003, What is the role of beta-adrenergic signaling in heart failure?, Circ Res, 93, 896, 10.1161/01.RES.0000102042.83024.CA Planavila, 2013, Fibroblast growth factor 21 protects against cardiac hypertrophy in mice, Nat Commun, 4, 2019, 10.1038/ncomms3019 Vergaro, 2016, Inhibition of galectin-3 pathway prevents isoproterenol-induced left ventricular dysfunction and fibrosis in mice, Hypertension, 67, 606, 10.1161/HYPERTENSIONAHA.115.06161 Allawadhi, 2018, Isoproterenol-induced cardiac ischemia and fibrosis: plant-based approaches for intervention, Phytother Res, 32, 1908, 10.1002/ptr.6152 Chandrasekar, 2004, Beta-adrenergic stimulation induces interleukin-18 expression via beta2-AR, PI3K, Akt, IKK, and NF-kappaB, Biochem Biophys Res Commun, 319, 304, 10.1016/j.bbrc.2004.04.185 Murray, 2000, Chronic beta-adrenergic stimulation induces myocardial proinflammatory cytokine expression, Circulation, 101, 2338, 10.1161/01.CIR.101.20.2338 Prabhu, 2000, Beta-adrenergic blockade in developing heart failure: effects on myocardial inflammatory cytokines, nitric oxide, and remodeling, Circulation, 101, 2103, 10.1161/01.CIR.101.17.2103 Van Snick, 1989, Cloning and characterization of a cDNA for a new mouse T cell growth factor (P40), J Exp Med, 169, 363, 10.1084/jem.169.1.363 Zhao, 2013, IL-9 and Th9 cells: progress and challenges, Int Immunol, 25, 547, 10.1093/intimm/dxt039 Vermeer, 2003, Interleukin-9 induces goblet cell hyperplasia during repair of human airway epithelia, Am J Respir Cell Mol Biol, 28, 286, 10.1165/rcmb.4887 Gounni, 2004, IL-9-mediated induction of eotaxin1/CCL11 in human airway smooth muscle cells, J Immunol, 173, 2771, 10.4049/jimmunol.173.4.2771 Levitt, 1999, IL-9 pathway in asthma: new therapeutic targets for allergic inflammatory disorders, J Allergy Clin Immunol, 103, S485, 10.1016/S0091-6749(99)70165-X Baeck, 2018, Increased expression of interleukin-9 in patients with allergic contact dermatitis caused by p-phenylenediamine, Contact Dermatitis, 79, 346, 10.1111/cod.13123 Gerlach, 2014, TH9 cells that express the transcription factor PU.1 drive T cell-mediated colitis via IL-9 receptor signaling in intestinal epithelial cells, Nat Immunol, 15, 676, 10.1038/ni.2920 Elyaman, 2017, Th9 cells in the pathogenesis of EAE and multiple sclerosis, Semin Immunopathol, 39, 79, 10.1007/s00281-016-0604-y Kundu-Raychaudhuri, 2016, IL-9, a local growth factor for synovial T cells in inflammatory arthritis, Cytokine, 79, 45, 10.1016/j.cyto.2015.12.020 Yuan, 2015, IL-9 antibody injection suppresses the inflammation in colitis mice, Biochem Biophys Res Commun, 468, 921, 10.1016/j.bbrc.2015.11.057 Cappuzzello, 2011, Increase of plasma IL-9 and decrease of plasma IL-5, IL-7, and IFN-gamma in patients with chronic heart failure, J Transl Med, 9, 28, 10.1186/1479-5876-9-28 Marra, 2016, Detectable interleukin-9 plasma levels are associated with impaired cardiopulmonary functional capacity and all-cause mortality in patients with chronic heart failure, Int J Cardiol, 209, 114, 10.1016/j.ijcard.2016.02.017 Liggett, 2008, A GRK5 polymorphism that inhibits beta-adrenergic receptor signaling is protective in heart failure, Nat Med, 14, 510, 10.1038/nm1750 Ye, 2017, Interleukin 22 promotes blood pressure elevation and endothelial dysfunction in angiotensin II-treated mice, J Am Heart Assoc, 6 Ye, 2018, Interleukin-12p35 knock out aggravates doxorubicin-induced cardiac injury and dysfunction by aggravating the inflammatory response, oxidative stress, apoptosis and autophagy in mice, Ebiomedicine, 35, 29, 10.1016/j.ebiom.2018.06.009 Liu, 2015, Toll-like receptor 5 deficiency attenuates interstitial cardiac fibrosis and dysfunction induced by pressure overload by inhibiting inflammation and the endothelial-mesenchymal transition, Biochim Biophys Acta, 1852, 2456, 10.1016/j.bbadis.2015.08.013 Ye, 2019, Interleukin-12p35 knockout promotes macrophage differentiation, aggravates vascular dysfunction, and elevates blood pressure in angiotensin II-infused mice, Cardiovasc Res, 115, 1102, 10.1093/cvr/cvy263 Ye, 2018, Increased kielin/chordin-like protein levels are associated with the severity of heart failure, Clin Chim Acta, 486, 381, 10.1016/j.cca.2018.08.033 Ye, 2017, Anti-interleukin-22-neutralizing antibody attenuates angiotensin II-induced cardiac hypertrophy in mice, Mediators Inflamm, 2017, 5635929, 10.1155/2017/5635929 Brooks, 2009, Isoproterenol-induced myocardial injury and diastolic dysfunction in mice: structural and functional correlates, Comp Med, 59, 339 Chen, 2016, DNA methylation indicates susceptibility to isoproterenol-induced cardiac pathology and is associated with chromatin states, Circ Res, 118, 786, 10.1161/CIRCRESAHA.115.305298 Zhuo, 2013, Isoproterenol instigates cardiomyocyte apoptosis and heart failure via AMPK inactivation-mediated endoplasmic reticulum stress, Apoptosis, 18, 800, 10.1007/s10495-013-0843-5 Bristow, 2000, Beta-adrenergic receptor blockade in chronic heart failure, Circulation, 101, 558, 10.1161/01.CIR.101.5.558 Oh, 2011, Biology of the interleukin-9 pathway and its therapeutic potential for the treatment of asthma, Inflamm Allergy Drug Targets, 10, 180, 10.2174/187152811795564073 Lauwerys, 2000, Cytokine production and killer activity of NK/T-NK cells derived with IL-2, IL-15, or the combination of IL-12 and IL-18, J Immunol, 165, 1847, 10.4049/jimmunol.165.4.1847 Li, 2011, IL-9 is important for T-cell activation and differentiation in autoimmune inflammation of the central nervous system, Eur J Immunol, 41, 2197, 10.1002/eji.201041125 Zhang, 2015, IL-9 aggravates the development of atherosclerosis in ApoE-/- mice, Cardiovasc Res, 106, 453, 10.1093/cvr/cvv110 Oudit, 2003, Phosphoinositide 3-kinase gamma-deficient mice are protected from isoproterenol-induced heart failure, Circulation, 108, 2147, 10.1161/01.CIR.0000091403.62293.2B Freund, 2005, Requirement of nuclear factor-kappaB in angiotensin II- and isoproterenol-induced cardiac hypertrophy in vivo, Circulation, 111, 2319, 10.1161/01.CIR.0000164237.58200.5A Xiao, 2018, IL-18 cleavage triggers cardiac inflammation and fibrosis upon beta-adrenergic insult, Eur Heart J, 39, 60, 10.1093/eurheartj/ehx261 Garlie, 2011, Tumor necrosis factor receptor 2 signaling limits beta-adrenergic receptor-mediated cardiac hypertrophy in vivo, Basic Res Cardiol, 106, 1193, 10.1007/s00395-011-0196-6 Prabhu, 2003, Beta-adrenergic receptor blockade modulates Bcl-X(S) expression and reduces apoptosis in failing myocardium, J Mol Cell Cardiol, 35, 483, 10.1016/S0022-2828(03)00052-X Noelle, 2010, Cellular sources and immune functions of interleukin-9, Nat Rev Immunol, 10, 683, 10.1038/nri2848 Neurath, 2016, IL-9 signaling as key driver of chronic inflammation in mucosal immunity, Cytokine Growth Factor Rev, 29, 93, 10.1016/j.cytogfr.2016.02.002 Geng, 2018, IL-9 exhibits elevated expression in osteonecrosis of femoral head patients and promotes cartilage degradation through activation of JAK-STAT signaling in vitro, Int Immunopharmacol, 60, 228, 10.1016/j.intimp.2018.05.005